Cite

HARVARD Citation

    Mantia, C. et al. (2022). Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors. Melanoma research. 32 (1), p. . [Online]. 
  
Back to record